Who should be prioritised for COVID-19 vaccines?
作者信息
Hassan-Smith Zaki, Hanif Wasim, Khunti Kamlesh
机构信息
University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TT, UK.
University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TT, UK.
出版信息
Lancet. 2020 Nov 28;396(10264):1732-1733. doi: 10.1016/S0140-6736(20)32224-8. Epub 2020 Oct 27.
Abstract
摘要
相似文献
1
Who should be prioritised for COVID-19 vaccines?
Lancet. 2020 Nov 28;396(10264):1732-1733. doi: 10.1016/S0140-6736(20)32224-8. Epub 2020 Oct 27.
2
Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?
JAMA. 2020 Nov 24;324(20):2023-2024. doi: 10.1001/jama.2020.20571.
3
COVID-19 vaccine prioritisation for type 1 and type 2 diabetes.
Lancet Diabetes Endocrinol. 2021 Mar;9(3):140-141. doi: 10.1016/S2213-8587(21)00017-6. Epub 2021 Jan 18.
4
Equitable access to COVID-19 vaccination: a distant dream?
Eur J Public Health. 2020 Dec 11;30(6):1039-1040. doi: 10.1093/eurpub/ckaa190.
5
Vaccinating the UK against covid-19.
BMJ. 2020 Nov 30;371:m4654. doi: 10.1136/bmj.m4654.
6
Experts call to include prisons in COVID-19 vaccine plans.
Lancet. 2020 Dec 12;396(10266):1870. doi: 10.1016/S0140-6736(20)32663-5.
7
Tackling inequitable distribution of the COVID-19 vaccine.
Br J Community Nurs. 2021 Jan 2;26(1):48-49. doi: 10.12968/bjcn.2021.26.1.48.
8
An African plan to control COVID-19 is urgently needed.
Lancet. 2020 Dec 5;396(10265):1777. doi: 10.1016/S0140-6736(20)32580-0.
9
Audio Interview: SARS-CoV-2 Vaccination and Vulnerable Populations.
N Engl J Med. 2020 Dec 10;383(24):e143. doi: 10.1056/NEJMe2034906.
10
Status of vaccine development for COVID-19.
Br J Community Nurs. 2020 Dec 2;25(12):620-621. doi: 10.12968/bjcn.2020.25.12.620.
引用本文的文献
1
COVID-19 and older people's wellbeing in northern KwaZulu-Natal - the importance of relationships.
Wellcome Open Res. 2024 Jun 19;7:168. doi: 10.12688/wellcomeopenres.17841.4. eCollection 2022.
2
Leukopenia and leukocytosis as strong predictors of COVID-19 severity: A cross-sectional study of the hematologic abnormalities and COVID-19 severity in hospitalized patients.
Health Sci Rep. 2023 Sep 27;6(10):e1574. doi: 10.1002/hsr2.1574. eCollection 2023 Oct.
3
COVID-19 immunity and vaccines: what a pharmacist needs to know.
Asian Biomed (Res Rev News). 2021 Apr 30;15(2):51-67. doi: 10.2478/abm-2021-0008. eCollection 2021 Apr.
4
Endothelium dysfunction and thrombosis in COVID-19 with type 2 diabetes.
Endocrine. 2023 Oct;82(1):15-27. doi: 10.1007/s12020-023-03439-y. Epub 2023 Jul 1.
5
Optimizing Access to the COVID-19 Vaccination for People Experiencing Homelessness.
Int J Environ Res Public Health. 2022 Nov 25;19(23):15686. doi: 10.3390/ijerph192315686.
6
Understanding COVID-19 Vaccine Hesitancy in Ethnic Minorities Groups in the UK.
Front Public Health. 2022 Jul 1;10:917242. doi: 10.3389/fpubh.2022.917242. eCollection 2022.
7
Willingness to receive COVID-19 vaccine and associated factors among adult chronic patients. A cross-sectional study in Northwest Ethiopia.
PLoS One. 2022 Jul 12;17(7):e0269942. doi: 10.1371/journal.pone.0269942. eCollection 2022.
8
Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants.
Epidemiol Infect. 2022 Jan 24;150:e46. doi: 10.1017/S0950268822000139.
9
SARS-CoV-2 infection: efficacy of extensive vaccination of the healthcare workforce in a large Italian hospital.
Med Lav. 2021 Dec 23;112(6):465-476. doi: 10.23749/mdl.v112i6.12124.
10
COVID-19: an outbreak in a nursing home in spring 2021.
Acta Biomed. 2021 Oct 7;92(S6):e2021445. doi: 10.23750/abm.v92iS6.12231.
本文引用的文献
1
Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study.
Lancet Diabetes Endocrinol. 2020 Oct;8(10):813-822. doi: 10.1016/S2213-8587(20)30272-2. Epub 2020 Aug 13.
2
Planning for a COVID-19 Vaccination Program.
JAMA. 2020 Jun 23;323(24):2458-2459. doi: 10.1001/jama.2020.8711.
Zotero 插件